默克300亿天价收购传闻背后的RAS革命:Revolution Medicines的“三元复合物”平台,揭秘“分子胶水”技术如何破解癌症“死亡之星”KRAS

医道社创新药新...
Jan 11

医道社:传承和发展民间中医来源:海外网站 作者:医道社整理版权归原作者所有,如有违规、侵权请联系我们删除!关注不迷路,更多创新药前沿资讯大家好,我是你们的创新药专业博主老汤。作为临床医生和药品研发人员,你们每天面对的肿瘤患者中,RAS突变型癌症占比不小吧?那些KRAS G12C、G12D突变的肺癌、胰腺癌、结直肠癌,总让人觉得棘手——传统靶向药效果有限,耐药来得快。今天,我们来聊聊...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10